Method for treating diastolic heart failure by inhibiting galectin-3
AssigneeHenry Ford Health System
InventorHani N. SABBAH
Life of this patent
Estimating the term…
Abstract
A method for treating diastolic heart failure (heart failure with preserved ejection fraction (HFpEF)) in a subject in need thereof is provided including administering a therapeutically effective amount of a galectin-3 inhibitor to the subject.
Claims20
A method for treating heart failure with preserved ejection fraction (HFpEF) in a subject in need thereof, the method comprising:
- administering a therapeutically effective amount of a galectin-3 inhibitor to the subject.
A method for treating a subject exhibiting at least one symptom of heart failure with preserved ejection fraction (HFpEF), the method comprising:
- administering a therapeutically effective amount of an inhibitor of galectin-3 to the subject.
A method for treating diastolic heart failure in a subject with a left ventricular ejection fraction of greater than about 45%, the method comprising:
- administering a therapeutically effective amount of N-acetyl-D-lactosamine (LacNAc) to the subject.
Dependencies are inferred from the claim text.